Outlook Therapeutics

$1.21
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-2.42%) Today

$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell OTLK and other stocks, options, and ETFs commission-free!

About OTLK

Outlook Therapeutics, Inc. Common Stock, also called Outlook Therapeutics, is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ. The listed name for OTLK is Outlook Therapeutics, Inc. Common Stock.

CEO

Lawrence A. Kenyon

Employees

Headquarters

South Brunswick, New Jersey

Founded

2010

Market Cap

153.89M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.50M

High Today

$1.31

Low Today

$1.20

Open Price

$1.27

Volume

932.29K

52 Week High

$1.74

52 Week Low

$0.499

Collections

OTLK Earnings

-$0.62

-$0.40

-$0.17

$0.05

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Dec 17, Pre-Market